These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6195199)

  • 41. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
    Andersson S; Nemeth A; Ohisalo J; Strandvik B
    Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.
    Curtius HC; Völlmin JA; Baerlocher K
    Clin Chim Acta; 1972 Mar; 37():277-85. PubMed ID: 5022091
    [No Abstract]   [Full Text] [Related]  

  • 44. Phenylalanine-tyrosine deficiency syndrome as a complication of the management of hereditary tyrosinemia.
    Cohn RM; Yudkoff M; Yost B; Segal S
    Am J Clin Nutr; 1977 Feb; 30(2):209-14. PubMed ID: 835507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Incurable keratitis and chronic palmoplantar hyperkeratosis with hypertyrosinemia. Cure using a tyrosine-restricted diet. Type II tyrosinemia].
    Hervé F; Moreno JL; Ogier H; Saudubray JM; De Prost Y; Duffier JL; Charpentier C; Lemonnier F; Frézal J
    Arch Fr Pediatr; 1986 Jan; 43(1):19-22. PubMed ID: 2939812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tyrosinemia and Richner-Hanhart syndrome (an autosomal recessive hereditary metabolic disease of childhood with bilateral dendritic pseudokeratitis, keratosis palmaris et plantaris and mental deficiency)].
    Jaeger W; Gallasch G; Schnyder UW; Lutz P; Schmidt H
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1978; (75):649-54. PubMed ID: 154319
    [No Abstract]   [Full Text] [Related]  

  • 47. Maternal tyrosinaemia II: management and successful outcome.
    Francis DE; Kirby DM; Thompson GN
    Eur J Pediatr; 1992 Mar; 151(3):196-9. PubMed ID: 1350979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.
    Whelan DT; Zannoni VG
    Biochem Med; 1974 Jan; 9(1):19-31. PubMed ID: 4150247
    [No Abstract]   [Full Text] [Related]  

  • 49. Tyrosinaemia II.
    Colditz PB; Yu JS; Billson FA; Rogers M; Molloy HF; O'Halloran M; Wilcken B
    Med J Aust; 1984 Aug; 141(4):244-5. PubMed ID: 6482766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary phenolic acids in tyrosinemia. Identification and quantitation by gas chromatography-mass spectrometry.
    Crawhall JC; Mamer O; Tjoa S; Claveau JC
    Clin Chim Acta; 1971 Aug; 34(1):47-54. PubMed ID: 5118727
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II).
    Sayar RB; von Domarus D; Schäfer HJ; Beckenkamp G
    Ophthalmologica; 1988; 197(1):1-6. PubMed ID: 3054681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Richner-Hanhart syndrome detected by expanded newborn screening.
    Meissner T; Betz RC; Pasternack SM; Eigelshoven S; Ruzicka T; Kruse R; Laitenberger G; Mayatepek E
    Pediatr Dermatol; 2008; 25(3):378-80. PubMed ID: 18577048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Richner-Hanhart's syndrome: new ultrastructural observations on skin lesions of two cases.
    el-Shoura SM; Tallab TM
    Ultrastruct Pathol; 1997; 21(1):51-6. PubMed ID: 9029766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dietary management of hereditary tyrosinemia. Apropos of 7 cases].
    Jehan P; Buchman M; Odièvre M
    Ann Pediatr (Paris); 1984 Jan; 31(1):33-40. PubMed ID: 6712098
    [No Abstract]   [Full Text] [Related]  

  • 55. Tyrosinemia type II (Richner-Hanhart syndrome): a new mutation in the TAT gene.
    Culic V; Betz RC; Refke M; Fumic K; Pavelic J
    Eur J Med Genet; 2011; 54(3):205-8. PubMed ID: 21145993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new form of prolonged transient tyrosinemia presenting with severe metabolic acidosis.
    Danks DM; Tippett P; Rogers J
    Acta Paediatr Scand; 1975 Mar; 64(2):209-14. PubMed ID: 1130176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW; Dakshinamurti K; Allan L; Haworth JC
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract]   [Full Text] [Related]  

  • 58. [Changes in the keratinocytes in oculo-cutaneous tyrosinosis: Richner-Hanhart syndrome (author's transl)].
    Larrègue M; De Giacomoni P; Odièvre P; Prigent F
    Ann Dermatol Venereol; 1980; 107(11):1023-30. PubMed ID: 7235483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tyrosinemia II].
    Kalimo K; Ivaska K; Koistinen T; Havu VK
    Duodecim; 1985; 101(16):1585-9. PubMed ID: 2865123
    [No Abstract]   [Full Text] [Related]  

  • 60. The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
    Kennaway NG; Buist NR; Fellman JH
    Clin Chim Acta; 1972 Oct; 41():157-61. PubMed ID: 4405100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.